KCKexin Chen

Kexin Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kexin Chen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tumor Habitat and Global Radiomics on DCE-MRI-Derived Metrics Enable Visualization and Quantification of Breast Cancer Spatio-temporal Hemodynamic Heterogeneity

    by Kexin Chen, Ya Ren, Xuetong Tao, Lin Li, Meng Wang, Shuluan Chen, Jie Wen, Sha Feng, Wei Cui, Yuan Guo, et al.

    Background Breast tumors exhibit substantial intratumoral hemodynamic heterogeneity associated with diagnostic uncertainty, yet conventional radiomics relies on whole-lesion analysis and does not capture spatially distinct functional subregions. This study aimed to develop a quantitative approach to visualize and quantify intratumor spatio-temporal hemodynamic heterogeneity and validate its clinical utility by distinguishing benign and malignant breast lesions. Methods 805 patients with preoperative breast MRI scans were retrospectively collected from two academic institutions between June 2018 and December 2023. Tumor voxels within manually segmented lesions were stratified by wash-in rate and wash-out enhancement, and K-means clustering enabled subregional habitat segmentation. Radiomics features were extracted from both the whole tumor and each habitat. Seven predictive models were developed using conventional radiomics features, habitat radiomics features, or their combinations derived from wash-in and wash-out maps. Model performance was evaluated using the area under the receiver operating characteristic curve, and comparisons were performed using the Friedman test. This framework integrates dynamic contrast–based habitat analysis with semi-quantitative parametric map-based radiomics, aiming to better capture intratumoral hemodynamic heterogeneity. Findings The study included 805 women (49 years ± 12) with 923 breast lesions (652 malignant and 271 benign). A total of 594 patients were assigned to the training and internal validation cohorts, and 211 patients were assigned to the external validation cohort. The combined model achieved the highest diagnostic performance, with AUCs of 0.920, 0.896, and 0.952 in the training, internal validation, and external validation cohorts, respectively, which significantly outperformed both the wash in-out radiomics model (AUCs: 0.899, 0.877, 0.911; p<0.001 ) and the wash in-out habitat model (AUCs: 0.861, 0.836, 0.923; p<0.001). Interpretation Tumor habitat and global radiomics based on DCE-MRI–derived kinetic metrics enable visualization and quantification of intratumoral hemodynamic heterogeneity and improve diagnostic performance for differentiating benign and malignant breast lesions.

  • Open Access

    Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Radiomics Features of Voxel-Wise DCE-MRI Time-Intensity-Curve Profile Maps

    by Ya Ren, Kexin Chen, Meng Wang, Jie Wen, Sha Feng, Honghong Luo, Cuiju He, Yuan Guo, Dehong Luo, Xin Liu, et al.

    Objective: Axillary lymph node (ALN) status in breast cancer is pivotal for guiding treatment and determining prognosis. The study aimed to explore the feasibility and efficacy of a radiomics model using voxel-wise dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) time-intensity-curve (TIC) profile maps to predict ALN metastasis in breast cancer. Methods: A total of 615 breast cancer patients who underwent preoperative DCE-MRI from October 2018 to February 2024 were retrospectively enrolled and randomly allocated into training (n = 430) and testing (n = 185) sets (7:3 ratio). Based on wash-in rate, wash-out enhancement, and wash-out stability, each voxel within manually segmented 3D lesions that were categorized into 1 of 19 TIC subtypes from the DCE-MRI images. Three feature sets were derived: composition ratio (type-19), radiomics features of TIC subtypes (type-19-radiomics), and radiomics features of third-phase DCE-MRI (phase-3-radiomics). Student’s t-test and the least absolute shrinkage and selection operator (LASSO) was used to select features. Four models (type-19, type-19-radiomics, type-19-combined, and phase-3-radiomics) were constructed by a support vector machine (SVM) to predict ALN status. Model performance was assessed using sensitivity, specificity, accuracy, F1 score, and area under the curve (AUC). Results: The type-19-combined model significantly outperformed the phase-3-radiomics model (AUC = 0.779 vs. 0.698, p < 0.001; 0.674 vs. 0.559) and the type-19 model (AUC = 0.779 vs. 0.541, p < 0.001; 0.674 vs. 0.435, p < 0.001) in cross-validation and independent testing sets. The type-19-radiomics showed significantly better performance than the phase-3-radiomics model (AUC = 0.764 vs. 0.698, p = 0.002; 0.657 vs. 0.559, p = 0.037) and type-19 model (AUC = 0. 764 vs. 0.541, p < 0.001; 0.657 vs. 0.435, p < 0.001) in cross-validation and independent testing sets. Among four models, the type-19-combined model achieved the highest AUC (0.779, 0.674) in cross-validation and testing sets. Conclusions: Radiomics analysis of voxel-wise DCE-MRI TIC profile maps, simultaneously quantifying temporal and spatial hemodynamic heterogeneity, provides an effective, noninvasive method for predicting ALN metastasis in breast cancer.